NV Industriebank LIOF Founded 1975
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 13
Rounds per year 0.28
Lead investments 2
Exits 2
Stages of investment
Early Stage Venture
Areas of investment
Agriculture
Biotechnology
Enterprise
Health Care
Industrial
Summary

NV Industriebank LIOF is the famous Corporate Investor, which was founded in 1975. The company was established in Europe in The Netherlands. The leading representative office of defined Corporate Investor is situated in the Maastricht.

The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2016. Comparing to the other companies, this NV Industriebank LIOF performs on 1 percentage points more the average number of lead investments. The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 3 participants. Despite the NV Industriebank LIOF, startups are often financed by Nedermaas Hightech Ventures, Ysios Capital, Thuja Capital. The meaningful sponsors for the fund in investment in the same round are Limburg Ventures, Nedermaas Hightech Ventures, Chemelot Ventures. In the next rounds fund is usually obtained by Health Innovation Fund, Thuja Capital, Sandbridge Capital.

The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Phenospex, FABPulous, Ekompany. For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands. Among the most successful fund investment fields, there are Recycling, Agriculture. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Neuroplast
Alternative Medicine
Therapeutics
Funding Round
4M19 Feb 2020 Netherlands, " The Netherlands"}
Vacis
Biotechnology
Chemical Engineering
Health Care
11 Oct 2019 Netherlands, " The Netherlands"}
Paztir
Automotive
Security
Early Stage Venture
17 Jul 2019 Netherlands, " The Netherlands"}
Cristal Therapeutics
Biotechnology
Medical
Pharmaceutical
Therapeutics
Venture - Series Unknown
15M19 Jan 2017 Netherlands, " The Netherlands"}
28 Aug 2015
Quality Circular Polymers
Plastics and Rubber Manufacturing
Recycling
Sustainability
Funding Round
41M17 Apr 2014 Netherlands, " The Netherlands"}
Ekompany
Agriculture
Chemical
Energy Efficiency
Manufacturing
Venture - Series Unknown
13M06 Mar 2013 Netherlands, " The Netherlands"}
Phenospex
Agriculture
Life Science
Seed
589K13 Dec 2011 Netherlands, Heerlen
MagnaMedics
Biotechnology
Nanotechnology
Project Management
Early Stage Venture
01 Feb 2011 Netherlands, " The Netherlands"}
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NV Industriebank LIOF?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: